Hospital
Wheaton Franciscan Healthcare - Franklin, INC.
Wheaton Franciscan Healthcare - Franklin, INC. was paid $436K by Medicaid between Jan 2018 and May 2018, across 88 billing codes. Its largest line is 96361, Intravenous infusion, hydration; each additional hour — 13% of everything it billed.
33Billing provider infoWHEATON FRANCISCAN HEALTHCARE - FRANKLIN, INC.
FRANKLIN, WI 53132
FRANKLIN, WI 53132
33aNPI1457479552assigned 03/27/2007
33bProvider typeGeneral Acute Care Hospital
28Total paid$436K
24GClaims15,517
24DCodes billed88
24AFirst – last monthJan 2018 – May 2018
Compared with peers
Next to other General Acute Care Hospital providers in Wisconsin
Rank by total paid#48 of 60
Median peer was paid$2.90M
This provider vs. median0.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,517 | $436K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 96361 | Intravenous infusion, hydration; each additional hour | 13% | 402 | 359 | $55K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 11% | 1,149 | 334 | $49K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 10% | 924 | 846 | $45K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 10% | 838 | 792 | $44K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.1% | 414 | 380 | $22K |
| 80053 | Comprehensive metabolic panel | 4.0% | 652 | 605 | $17K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 3.9% | 690 | 229 | $17K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3.9% | 168 | 159 | $17K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 3.6% | 85 | 81 | $16K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.9% | 186 | 174 | $13K |
| 87081 | 2.2% | 207 | 201 | $10K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 2.1% | 69 | 60 | $9K |
76 more codes
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 2.1% | 101 | $9K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.7% | 128 | $7K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.7% | 132 | $7K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.6% | 935 | $7K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.5% | 380 | $7K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.5% | 87 | $7K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.4% | 142 | $6K |
| 81001 | 1.3% | 461 | $6K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1.1% | 90 | $5K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.1% | 230 | $5K |
| 81025 | <1% | 368 | $4K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 69 | $4K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 116 | $4K |
| 82962 | <1% | 206 | $4K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 38 | $4K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 412 | $3K |
| 97161 | <1% | 67 | $3K | |
| 81003 | <1% | 277 | $3K | |
| 84484 | <1% | 276 | $2K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 15 | $2K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 52 | $2K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 52 | $2K |
| 83690 | <1% | 245 | $2K | |
| 97162 | <1% | 43 | $2K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 65 | $2K |
| 82565 | <1% | 47 | $1K | |
| 76830 | Ultrasound, transvaginal | <1% | 16 | $1K |
| 85610 | <1% | 148 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 132 | $915.47 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 55 | $906.45 |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 33 | $883.25 |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 14 | $718.48 |
| 82550 | <1% | 60 | $667.66 | |
| 83605 | <1% | 76 | $605.75 | |
| 85027 | <1% | 81 | $546.24 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 453 | $501.20 |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 15 | $494.46 |
| 80061 | Lipid panel | <1% | 32 | $476.14 |
| 74018 | <1% | 26 | $402.79 | |
| 80076 | <1% | 39 | $341.25 | |
| 85730 | <1% | 52 | $282.34 | |
| 71045 | Radiologic examination, chest; single view | <1% | 185 | $261.82 |
| 83880 | <1% | 14 | $238.88 | |
| 85379 | <1% | 28 | $236.40 | |
| 82553 | <1% | 38 | $190.95 | |
| 87040 | <1% | 12 | $171.52 | |
| 87186 | <1% | 27 | $167.98 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 18 | $162.54 |
| 86901 | <1% | 44 | $142.28 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 17 | $126.75 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 451 | $120.77 |
| 73630 | <1% | 29 | $107.55 | |
| 72100 | <1% | 12 | $83.90 | |
| 86900 | <1% | 15 | $77.23 | |
| 86850 | <1% | 13 | $64.83 | |
| 73610 | <1% | 27 | $64.80 | |
| 83735 | <1% | 14 | $64.15 | |
| 73564 | <1% | 13 | $48.80 | |
| 73502 | <1% | 12 | $32.00 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 330 | $28.23 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 196 | $9.83 |
| 36415 | Collection of venous blood by venipuncture | <1% | 114 | $3.00 |
| J2704 | Injection, propofol, 10 mg | <1% | 189 | $2.37 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 186 | $2.17 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 336 | $0.59 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 224 | $0.26 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 271 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 49 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 100 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 126 | $0.00 |
| 96376 | 0% | 13 | $0.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 57 | $0.00 |
| 94760 | 0% | 170 | $0.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 71 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 17 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 49 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDICUS-JOHNSON, COREEN (PRESIDENT)